Pharmaceutical Executive, Jan 1, 2011 - Pharmaceutical Executive

ADVERTISEMENT

Pharmaceutical Executive, Jan 1, 2011
Features
Managing Clinical Trials in Emerging Markets
Amgen's hub-and-spoke system combines control at home with the flexibility to respond to local needs
The San Diego Story
By William Looney
Building the commercial and policy base for effective collaboration in biotech
The Steep, Slow Climb
By Walter Armstrong
A surve of leading experts reveals 2011's sobering reality and the trends that smart drugmakers will follow into the next decade
From the Editor
The Night Stalkers: Keeping CEOs Awake in 2011
By William Looney
"Tops in Fraud" is a ruinous moniker for pharma—a business so dependent on basic issues of trust, integrity, quality and safety
The Night Stalkers
By William Looney
"Tops in Fraud" is a ruinous moniker for pharma—a business so dependent on basic issues of trust, integrity, quality and safety
Columns
Ensuring Drug Quality: A Complex Task in a Globalized Era
US Pharmacopeia has launched an ambitious moderniation campaign to ensure its standards keep pace with changes in the blobal marketplace
The List
By Walter Armstrong
It's a new year. Even pharma, with its glacial timelines, has its "Out with the old, in with the new" moment. Welcome to 2011!
The Right Mix for 2011
By Eric Boothe
Incorporating the proper blend of media into your marketing initiatives will help to increase the flexibility and success of your campaigns
Politics & PDUFA
By Jill Wechsler
Pharma companies will assess health reform, negotiate user fees and keep an eye on federal prosecutors in the year ahead

ADVERTISEMENT

Click here